|
|||||
|
|
A prospective surveillance study of inhibitor development in haemophilia A patients following a population switch to a third‐generation B‐domain‐deleted recombinant factor VIII |
|
| Authors: | E. Dubé A. Bonnefoy C. Merlen J.‐F. Castilloux S. Cloutier C. Demers C. A. Sabapathy J. St‐Louis C. Vezina M. Warner G.‐É. Rivard |
| Affiliation: | 1. Centre Hospitalier Universitaire Sainte‐Justine, Montréal, QC, Canada;2. Centre Hospitalier Universitaire de Sherbrooke, Université Sherbrooke, Sherbrooke, QC, Canada;3. Centre Hospitalier Universitaire de Québec, H?pital de l'Enfant Jésus, Québec, QC, Canada;4. McGill University Health Center, Montreal Children's Hospital, Montréal, QC, Canada;5. H?pital Maisonneuve‐Rosemont, Montréal, QC, Canada |
| Abstract: | |
| Keywords: | bleeds factor VIII usage haemophilia A inhibitor recombinant factor VIII switching products |